BACKGROUND: In Mauritania, some authors have described a possible high prevalence of hepatitis delta virus (HDV) infection in the 1990s in studies of small-size samples. OBJECTIVES: The aims of our study were to assess the prevalence of HDV in HBsAg positive blood donors in Mauritania, to identify the main risk factors for HDV transmission and to analyze genetic diversity of HDV strains. STUDY DESIGN: From October 2008 to December 2009, 11,100 consecutive blood donors were considered in this study. Among them, 1700 (15.3%) were HBsAg positive and 455 accepted to participate in this study. Demographic, epidemiological, ethnical, clinical and biological data were recorded. HDV screening, i.e., antibodies (HDVAb) and RNA (HDV-RNA) detection, was performed for all of them as well as HDV and HBV genotyping. RESULTS: Ninety/455 (19.78%) donors were HDVAb positive and HDV-RNA was detectable in 56 (62.2%) of them. HDV infection was significantly associated with older age, number of marriages, military profession, residence in the desert and a history of hospitalization. The HDV genotypes of the circulating strains were HDV-1 (89.3%) and HDV-5 (10.7%). CONCLUSION: HDV is highly endemic in Mauritanian blood donors indicating that a high number of them will develop chronic hepatitis, cirrhosis or hepatocellular carcinoma. Associated risk factors support nosocomial transmission of HDV. These data underline the need to reinforce HBV vaccination in newborns and in blood donors without HBV markers, together with screening for HDV in HBV-infected individuals.
BACKGROUND: In Mauritania, some authors have described a possible high prevalence of hepatitis delta virus (HDV) infection in the 1990s in studies of small-size samples. OBJECTIVES: The aims of our study were to assess the prevalence of HDV in HBsAg positive blood donors in Mauritania, to identify the main risk factors for HDV transmission and to analyze genetic diversity of HDV strains. STUDY DESIGN: From October 2008 to December 2009, 11,100 consecutive blood donors were considered in this study. Among them, 1700 (15.3%) were HBsAg positive and 455 accepted to participate in this study. Demographic, epidemiological, ethnical, clinical and biological data were recorded. HDV screening, i.e., antibodies (HDVAb) and RNA (HDV-RNA) detection, was performed for all of them as well as HDV and HBV genotyping. RESULTS: Ninety/455 (19.78%) donors were HDVAb positive and HDV-RNA was detectable in 56 (62.2%) of them. HDV infection was significantly associated with older age, number of marriages, military profession, residence in the desert and a history of hospitalization. The HDV genotypes of the circulating strains were HDV-1 (89.3%) and HDV-5 (10.7%). CONCLUSION:HDV is highly endemic in Mauritanian blood donors indicating that a high number of them will develop chronic hepatitis, cirrhosis or hepatocellular carcinoma. Associated risk factors support nosocomial transmission of HDV. These data underline the need to reinforce HBV vaccination in newborns and in blood donors without HBV markers, together with screening for HDV in HBV-infected individuals.
Authors: Antoine Jaquet; Boris Tchounga; Aristophane Tanon; Aklesso Bagny; Didier K Ekouevi; Hamar A Traore; Annie J Sasco; Moussa Maiga; François Dabis Journal: Int J Cancer Date: 2018-04-10 Impact factor: 7.396
Authors: Iris E Andernach; Lukas V Leiss; Zekiba S Tarnagda; Marc C Tahita; Jesse A Otegbayo; Joseph C Forbi; Sunday Omilabu; Ionela Gouandjika-Vasilache; Narcisse P Komas; Okwen P Mbah; Claude P Muller Journal: J Clin Microbiol Date: 2014-03-05 Impact factor: 5.948
Authors: Jean Jacques N Noubiap; Jobert Richie N Nansseu; Shalom Tchokfe Ndoula; Jean Joel R Bigna; Ahmadou M Jingi; Joël Fokom-Domgue Journal: BMC Public Health Date: 2015-05-02 Impact factor: 3.295
Authors: Alexandra Ducancelle; Pierre Abgueguen; Jacques Birguel; Wael Mansour; Adeline Pivert; Hélène Le Guillou-Guillemette; Jean-Jacques Sobnangou; Amélie Rameau; Jean-Marie Huraux; Françoise Lunel-Fabiani Journal: PLoS One Date: 2013-11-12 Impact factor: 3.240
Authors: Alexander J Stockdale; Mas Chaponda; Apostolos Beloukas; Richard Odame Phillips; Philippa C Matthews; Athanasios Papadimitropoulos; Simon King; Laura Bonnett; Anna Maria Geretti Journal: Lancet Glob Health Date: 2017-10 Impact factor: 26.763
Authors: Mohamed A Daw; Amina M Daw; Nadia E M Sifennasr; Aisha M Draha; Ahmed M Daw; Ali M Daw; Mohamed O Ahmed; Ebtisam S Mokhtar; Abdallah El-Bouzedi; Ibrahem M Daw Journal: ScientificWorldJournal Date: 2018-09-26